vedolizumab
takeda
[' vedo', 'thanks']
 that looks quite good for vedo as a secondary prophylaxis for colitis (caveats on retrospective study but most irae studies are). thanks for sharing this
Professor, Medical Oncology @UCSD; PI @Patel_Lab computational immunopathology; Phase 1 & thoracic/NSCLC immunotherapy, solid tumor cell therapy, irAEs (he/him)